These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 20520605)
1. Dose selection of corifollitropin alfa by modeling and simulation in controlled ovarian stimulation. de Greef R; Zandvliet AS; de Haan AF; Ijzerman-Boon PC; Marintcheva-Petrova M; Mannaerts BM Clin Pharmacol Ther; 2010 Jul; 88(1):79-87. PubMed ID: 20520605 [TBL] [Abstract][Full Text] [Related]
2. A randomized dose-response trial of a single injection of corifollitropin alfa to sustain multifollicular growth during controlled ovarian stimulation. Corifollitropin Alfa Dose-finding Study Group Hum Reprod; 2008 Nov; 23(11):2484-92. PubMed ID: 18684735 [TBL] [Abstract][Full Text] [Related]
3. Corifollitropin alfa doses based on body weight: clinical overview of drug exposure and ovarian response. Ledger WL; Fauser BC; Devroey P; Zandvliet AS; Mannaerts BM Reprod Biomed Online; 2011 Aug; 23(2):150-9. PubMed ID: 21665541 [TBL] [Abstract][Full Text] [Related]
4. Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency. Fauser BC; Mannaerts BM; Devroey P; Leader A; Boime I; Baird DT Hum Reprod Update; 2009; 15(3):309-21. PubMed ID: 19182099 [TBL] [Abstract][Full Text] [Related]
5. Corifollitropin alfa in a long GnRH agonist protocol: proof of concept trial. Fatemi HM; Oberyé J; Popovic-Todorovic B; Witjes H; Mannaerts B; Devroey P Fertil Steril; 2010 Oct; 94(5):1922-4. PubMed ID: 20149360 [TBL] [Abstract][Full Text] [Related]
6. Corifollitropin alfa, a long-acting follicle-stimulating hormone agonist for the treatment of infertility. Loutradis D; Drakakis P; Vlismas A; Antsaklis A Curr Opin Investig Drugs; 2009 Apr; 10(4):372-80. PubMed ID: 19337959 [TBL] [Abstract][Full Text] [Related]
7. Pharmacologic profiling of corifollitropin alfa, the first developed sustained follicle stimulant. Verbost P; Sloot WN; Rose UM; de Leeuw R; Hanssen RG; Verheijden GF Eur J Pharmacol; 2011 Jan; 651(1-3):227-33. PubMed ID: 21115001 [TBL] [Abstract][Full Text] [Related]
8. Corifollitropin alfa: a review of its use in controlled ovarian stimulation for assisted reproduction. Croxtall JD; McKeage K BioDrugs; 2011 Aug; 25(4):243-54. PubMed ID: 21815699 [TBL] [Abstract][Full Text] [Related]
9. [Value of serum inhibin B measurement in predicting ovarian response in controlled ovarian hyperstimulation for in vitro fertilization cycle]. Chen Y; Yu Q; Zhang YW; He FF; Sun ZY Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):368-71. PubMed ID: 16831355 [TBL] [Abstract][Full Text] [Related]
10. Corifollitropin alfa compared to daily FSH in controlled ovarian stimulation for in vitro fertilization: a meta-analysis. Fensore S; Di Marzio M; Tiboni GM J Ovarian Res; 2015 Jun; 8():33. PubMed ID: 26036214 [TBL] [Abstract][Full Text] [Related]
11. Ovarian response to 150 µg corifollitropin alfa in a GnRH-antagonist multiple-dose protocol: a prospective cohort study. Lerman T; Depenbusch M; Schultze-Mosgau A; von Otte S; Scheinhardt M; Koenig I; Kamischke A; Macek M; Schwennicke A; Segerer S; Griesinger G Reprod Biomed Online; 2017 May; 34(5):534-540. PubMed ID: 28285952 [TBL] [Abstract][Full Text] [Related]
12. A pilot study comparing corifollitropin alfa associated with hp-HMG versus high dose rFSH antagonist protocols for ovarian stimulation in poor responders. Mendret-Pellerin S; Leperlier F; Reignier A; Lefebvre T; Barrière P; Fréour T Hum Fertil (Camb); 2020 Jun; 23(2):93-100. PubMed ID: 30129813 [TBL] [Abstract][Full Text] [Related]
14. Corifollitropin alfa: a novel long-acting recombinant follicle-stimulating hormone agonist for controlled ovarian stimulation. Loutradis D; Vlismas A; Drakakis P Womens Health (Lond); 2010 Sep; 6(5):655-64. PubMed ID: 20887164 [TBL] [Abstract][Full Text] [Related]
15. Absorption, distribution, metabolism and excretion of corifollitropin alfa, a recombinant hormone with a sustained follicle-stimulating activity. van Schanke A; van de Wetering-Krebbers SF; Bos E; Sloot WN Pharmacology; 2010; 85(2):77-87. PubMed ID: 20110752 [TBL] [Abstract][Full Text] [Related]
16. Impact of patient characteristics on the pharmacokinetics of corifollitropin alfa during controlled ovarian stimulation. Zandvliet AS; Prohn M; de Greef R; van Aarle F; McCrary Sisk C; Stegmann BJ Br J Clin Pharmacol; 2016 Jul; 82(1):74-82. PubMed ID: 26991902 [TBL] [Abstract][Full Text] [Related]
17. A randomised controlled trial of 300 versus 225 IU recombinant FSH for ovarian stimulation in predicted normal responders by antral follicle count. Jayaprakasan K; Hopkisson J; Campbell B; Johnson I; Thornton J; Raine-Fenning N BJOG; 2010 Jun; 117(7):853-62. PubMed ID: 20353458 [TBL] [Abstract][Full Text] [Related]
18. Corifollitropin alfa: a new option to treat female infertility. de Lartigue J Drugs Today (Barc); 2011 Aug; 47(8):583-90. PubMed ID: 21850281 [TBL] [Abstract][Full Text] [Related]
19. [Dynamic assay of serum inhibin B and estradiol concentrations obtained after gonadotrophin therapy as predictors of ovarian response in vitro fertilization cycle]. Miao MF; Huang HF Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):114-7. PubMed ID: 16640861 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF. Fauser BC; Alper MM; Ledger W; Schoolcraft WB; Zandvliet A; Mannaerts BM; Reprod Biomed Online; 2011 Feb; 22 Suppl 1():S23-31. PubMed ID: 21575846 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]